Your browser doesn't support javascript.
loading
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL.
Aldoss, Ibrahim; Khaled, Samer K; Wang, Xiuli; Palmer, Joycelynne; Wang, Yan; Wagner, Jamie R; Clark, Mary C; Simpson, Jennifer; Paul, Jinny; Vyas, Vibhuti; Chien, Sheng-Hsuan; Stein, Anthony; Pullarkat, Vinod; Salhotra, Amandeep; Al Malki, Monzr M; Aribi, Ahmed; Sandhu, Karamjeet; Thomas, Sandra H; Budde, Lihua E; Marcucci, Guido; Brown, Christine E; Forman, Stephen J.
Afiliação
  • Aldoss I; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Khaled SK; Gehr Family Center for Leukemia Research, City of Hope, Duarte, California.
  • Wang X; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Palmer J; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Wang Y; Gehr Family Center for Leukemia Research, City of Hope, Duarte, California.
  • Wagner JR; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Clark MC; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Simpson J; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Paul J; T Cell Therapeutics Research Laboratories, City of Hope, Duarte, California.
  • Vyas V; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Chien SH; Department of Computational and Quantitative Sciences, Division of Biostatistics, Beckman Research Institute, City of Hope, Duarte, California.
  • Stein A; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Pullarkat V; Department of Computational and Quantitative Sciences, Division of Biostatistics, Beckman Research Institute, City of Hope, Duarte, California.
  • Salhotra A; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Al Malki MM; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Aribi A; T Cell Therapeutics Research Laboratories, City of Hope, Duarte, California.
  • Sandhu K; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Thomas SH; Department of Clinical and Translational Project Development, City of Hope, Duarte, California.
  • Budde LE; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Marcucci G; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Brown CE; Hematological Malignancies Research Institute, City of Hope, Duarte, California.
  • Forman SJ; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
Clin Cancer Res ; 29(4): 742-753, 2023 02 16.
Article em En | MEDLINE | ID: mdl-36255386
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article